Clinical Trial Update: Bryostatin 1 and Rituximab in Treating Patients With B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia [Phase 2]

View source ↗

Summary

Phase 2 trial update of Bryostatin-1 in combination with Rituximab for patients with B-cell non-Hodgkin lymphoma or chronic lymphocytic leukemia; the study stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Non-hodgkin Lymphoma
• Chronic Lymphocytic Leukemia

Drugs mentioned

• Bryostatin-1 (bryostatin-1)
• Rituximab (rituximab)

Snippet

Sponsor: National Institute on Aging (NIA) | Conditions: Leukemia, Lymphoma | Phase 2 | Status: COMPLETED